A carregar...
Mass balance and metabolite profiling of (14)C-guadecitabine in patients with advanced cancer
Purpose The objective of this mass balance trial was to determine the excretory pathways and metabolic profile of the novel anticancer agent guadecitabine in humans after administration of a (14)C-radiolabeled dose of guadecitabine. Experimental design Included patients received at least one cycle o...
Na minha lista:
| Publicado no: | Invest New Drugs |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7340650/ https://ncbi.nlm.nih.gov/pubmed/31605293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-019-00854-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|